Ledger.Open graph →
SEC Form D · filed June 21, 2021

Abata Therapeutics, Inc

Offering
$95.0M
Sold
$45.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Shelley Chu · CAMBRIDGE, MADirectorJohn Trzupek · CAMBRIDGE, MAExecAbbie Celniker · CAMBRIDGE, MAExec · DirectorLorence Kim · CAMBRIDGE, MADirectorSamantha Singer · CAMBRIDGE, MAExec · DirectorMitch Finer · CAMBRIDGE, MADirectorExpedition Fund III GP LP · Dallas, TXExec · DirectorJoshua Clemente · New York, NYDirectorRobert F. Garland · GREENWOOD VILLAGE, COExec · DirectorD. S. Ruegg · San Francisco, CADirectorRichard Ronald · San Francisco, CADirectorChristian Villela Klotz · Miami, FLExecBrian Hirsch · Cardiff-by-the-Sea, CADirectorRick Smith · Cardiff-by-the-Sea, CADirectorAllen Wolff · Cardiff-by-the-Sea, CADirectorBruce R. Winson · Dallas, TXExec · DirectorC & C Development Co., LLC · Tustin, CAExecLadell Robbins · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗